Christine Simons
Phoenix, AZNPI 1497381701
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.4% of the total across 343 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 43 manufacturers reported payments, led by AbbVie at 42.0% of the total. Reporting peaked in 2021 at $1,757 and has fallen 73.0% since, to $475 in 2025.
Across 343 payments — averaging $15.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Johnson & Johnson$244
- Novartis$235
- Pfizer$228
- Biohaven Pharmaceuticals, Inc.$218
- CSL Behring$205
- plus $2K from 37 others
What the payments were for
- Food & beverage$4,89694%
- Education$2906%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aimovig AutoinjectorErenumab-Aooe | 25 | $18,886 |
| Emgality PenGalcanezumab-Gnlm | 17 | $11,503 |
| Sumatriptan Succinate | 34 | $3,010 |
| Gabapentin | 41 | $1,468 |
| Levetiracetam | 19 | $1,431 |
| Duloxetine Hcl | 28 | $610 |
| Donepezil Hcl | 19 | $191 |
| Primidone | 12 | $165 |
| Topiramate | 15 | $139 |
| Memantine Hcl | 12 | $94 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Upsher-smith Laboratories LLCTopiramate | $87 | $13915 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. There are too few providers in Arizonaon file to place this against a meaningful peer group, so we don't.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.